Drug Shortage Report for ACT RALOXIFENE
| Report ID | 256459 |
| Drug Identification Number | 02358840 |
| Brand name | ACT RALOXIFENE |
| Common or Proper name | RALOXIFENE 60MG FC TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | RALOXIFENE HYDROCHLORIDE |
| Strength(s) | 60MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 |
| ATC code | G03XC |
| ATC description | OTHER SEX HORM. & MODULATORS OF THE GENITAL SYSTEM |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2025-05-01 |
| Estimated end date | 2025-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-05-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-05-02 | French | Compare |
| v1 | 2025-05-02 | English | Compare |
Showing 1 to 2 of 2